Search

Your search keyword '"N. Robinson-Smith"' showing total 51 results

Search Constraints

Start Over You searched for: Author "N. Robinson-Smith" Remove constraint Author: "N. Robinson-Smith" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
51 results on '"N. Robinson-Smith"'

Search Results

1. Validity of Hemodynamic Monitoring Using Inert Gas Rebreathing Method in Patients With Chronic Heart Failure and Those Implanted With a Left Ventricular Assist Device

2. Left Ventricular Filling Pressures Contribute to Exercise Limitation in Patients with Continuous Flow Left Ventricular Assist Devices

3. Markers of Right Ventricular Dysfunction Predict Maximal Exercise Capacity After Left Ventricular Assist Device Implantation

4. Using existing technology better: Improving outcomes with the HeartWare left ventricular assist device

5. First-in-man use of the MVAD axial-flow pump: Long-term outcome

6. Ventricular Assist Devices in Adults with Failing Systemic Right Ventricle: The Importance of Concomitant Tricuspid Valve Replacement

7. Myocardial Recovery Strategy with Decommissioning for the HeartWare Left Ventricular Assist Device

8. Initial conservative management strategy of HeartWare left ventricular assist device thrombosis with intravenous heparin or bivalirudin

9. P5418Anticoagulation management of heartware left ventricular assist device thrombosis: comparison of heparin and bivalirudin

10. P1672Late right heart failure predictors after left ventricular assist device implantation

11. P1677Elevation of right-sided pressures and right ventricular echocardiographic parameters: predictors of Exercise Limitation in Patients with Implanted Continuous Flow Left Ventricular Assist Devices

12. Effect of Preoperative Tricuspid and/or Mitral Regurgitation on Development of Late Right-Sided Heart Failure After Insertion of the HeartWare Left Ventricular Assist Device

13. Neutrophil to Lymphocyte Ratio Is Related to Thrombotic Complications and Survival in Continuous Flow Left Ventricular Assist Devices

14. A Simplified Temporary Right Ventricular Assist Device (RVAD) during LVAD Implantation - Low Risk, Easy to Do and Ideal for Patient Rehabilitation

15. Markers of Right Ventricle Dysfunction Predict Exercise Capacity on Left Ventricular Assist Device (LVAD) Patients

16. Elevation of Right-Sided Pressures and Right Ventricular Echocardiographic Parameters: Predictors of Exercise Limitation in Patients with Implanted Continuous Flow Left Ventricular Assist Devices

17. A Review of Ventricular Assist Device Patients Compliance in INR Reporting Using a New App-Based Programme Compared with Telephone Surveillance

18. P711Ventricular assist devices for failing systemic right ventricle in adults with prior atrial switch procedure and congenitally corrected transposition of the great arteries:responders vs non responders

19. Reducing readmissions of outpatients with LVADs

20. Four-year outcomes with third-generation centrifugal left ventricular assist devices in an era of restricted transplantation

21. Infection Predisposes to Thrombosis During Long Term VAD Support

22. Lack of Social Support is Not a Contraindication to VAD Therapy

23. Tricuspid Regurgitation Predicts Late Onset Right Heart Failure after Left Ventricular Assist Device Implantation

24. MSSA Bacteraemia Can Be Eliminated in LVAD Patients

25. Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device

26. Hemodynamic, Echocardiographic, and Exercise-Related Effects of the HeartWare Left Ventricular Assist Device in Advanced Heart Failure

28. Durable LeftVentricular Assist Device Therapy to Reduce Transpulmonary Gradient in Adult Congenital Heart Disease to Facilitate Heart Transplant

31. Impact of Aortic Valve Closure on Adverse Events and Outcomes with the HeartWare HVAD

32. 022 * NOVEL MINIMALLY INVASIVE DECOMMISSIONING OF HEARTWARE LEFT VENTRICULAR ASSIST DEVICE FOLLOWING MYOCARDIAL RECOVERY

33. Extended Bridge To Transplant: 4 Years Outcomes With 3rd Generation LVADs in an Era of Restricted Transplantation

36. 27 Improving Patient Satisfaction in Wound Care of Left Ventricular Assist Device Exit Sites

37. Ventricular assist devices in transposition and failing systemic right ventricle: role of tricuspid valve replacement.

38. Does infection predispose to thrombosis during long-term ventricular assist device support?

39. Using existing technology better: Improving outcomes with the HeartWare left ventricular assist device.

40. Validity of Hemodynamic Monitoring Using Inert Gas Rebreathing Method in Patients With Chronic Heart Failure and Those Implanted With a Left Ventricular Assist Device.

41. Markers of Right Ventricular Dysfunction Predict Maximal Exercise Capacity After Left Ventricular Assist Device Implantation.

42. Initial conservative management strategy of HeartWare left ventricular assist device thrombosis with intravenous heparin or bivalirudin.

43. Left Ventricular Filling Pressures Contribute to Exercise Limitation in Patients with Continuous Flow Left Ventricular Assist Devices.

44. Neutrophil to Lymphocyte Ratio Is Related to Thrombotic Complications and Survival in Continuous Flow Left Ventricular Assist Devices.

45. Effect of Preoperative Tricuspid and/or Mitral Regurgitation on Development of Late Right-Sided Heart Failure After Insertion of the HeartWare Left Ventricular Assist Device.

47. Myocardial Recovery Strategy with Decommissioning for the HeartWare Left Ventricular Assist Device.

48. Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device.

49. Development of de novo aortic valve incompetence in patients with the continuous-flow HeartWare ventricular assist device.

50. Four-year outcomes with third-generation centrifugal left ventricular assist devices in an era of restricted transplantation.

Catalog

Books, media, physical & digital resources